Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0)

Daiki Tohma; Shigeru Tajima; Fumihiro Kato; Hirotaka Sato; Michinori Kakisaka; Takayuki Hishiki; Michiyo Kataoka; Haruko Takeyama; Chang Kweng Lim; Yoko Aida; Masayuki Saijo

doi:10.1007/s00705-018-4107-0

Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0)

Daiki Tohma, Shigeru Tajima^*, Fumihiro Kato, Hirotaka Sato, Michinori Kakisaka, Takayuki Hishiki, Michiyo Kataoka, Haruko Takeyama, Chang Kweng Lim, Yoko Aida, Masayuki Saijo

^*この研究の対応する著者

先進理工学部

研究成果: Comment/debate › 査読

抄録

We would like to correct the information on the antibody used in this study. In Fig. 5 of the article, cellular β-actin was detected as an internal control using anti-β-actin antibody (Fujifilm Wako Pure Chemicals, #017-24573). Recently, however, the manufacturer/provider informed us that the antibody reacts with cellular γ1-actin, but do not react with cellular β-actin. Consequently, we detected cellular γ1-actin molecules in the experiment. Fortunately, expression pattern of γ1-actin is similar to that of β-actin in most of cultured cells and, therefore, the alteration of the target molecules does not affect our interpretations and conclusions. The name of the antibody has been corrected in the paper. We apologize for any inconvenience and confusion caused by this error.

本文言語	English
ページ（範囲）	235
ページ数	1
ジャーナル	Archives of Virology
巻	164
号	1
DOI	https://doi.org/10.1007/s00705-018-4107-0
出版ステータス	Published - 2019 1月 22

ASJC Scopus subject areas

ウイルス学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1007/s00705-018-4107-0

他のファイルとリンク

フィンガープリント

「Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Tohma, D., Tajima, S., Kato, F., Sato, H., Kakisaka, M., Hishiki, T., Kataoka, M., Takeyama, H., Lim, C. K., Aida, Y., & Saijo, M. (2019). Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0). Archives of Virology, 164(1), 235. https://doi.org/10.1007/s00705-018-4107-0

Tohma, D, Tajima, S, Kato, F, Sato, H, Kakisaka, M, Hishiki, T, Kataoka, M, Takeyama, H, Lim, CK, Aida, Y & Saijo, M 2019, 'Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0)', Archives of Virology, vol. 164, no. 1, pp. 235. https://doi.org/10.1007/s00705-018-4107-0

@article{2316161534b44a979edfdff43481a3be,

title = "Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0)",

abstract = "We would like to correct the information on the antibody used in this study. In Fig. 5 of the article, cellular β-actin was detected as an internal control using anti-β-actin antibody (Fujifilm Wako Pure Chemicals, #017-24573). Recently, however, the manufacturer/provider informed us that the antibody reacts with cellular γ1-actin, but do not react with cellular β-actin. Consequently, we detected cellular γ1-actin molecules in the experiment. Fortunately, expression pattern of γ1-actin is similar to that of β-actin in most of cultured cells and, therefore, the alteration of the target molecules does not affect our interpretations and conclusions. The name of the antibody has been corrected in the paper. We apologize for any inconvenience and confusion caused by this error.",

author = "Daiki Tohma and Shigeru Tajima and Fumihiro Kato and Hirotaka Sato and Michinori Kakisaka and Takayuki Hishiki and Michiyo Kataoka and Haruko Takeyama and Lim, {Chang Kweng} and Yoko Aida and Masayuki Saijo",

note = "Publisher Copyright: {\textcopyright} 2018, Springer-Verlag GmbH Austria, part of Springer Nature.",

year = "2019",

month = jan,

day = "22",

doi = "10.1007/s00705-018-4107-0",

language = "English",

volume = "164",

pages = "235",

journal = "Archives of Virology",

issn = "0304-8608",

publisher = "Springer Wien",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0)

AU - Tohma, Daiki

AU - Tajima, Shigeru

AU - Kato, Fumihiro

AU - Sato, Hirotaka

AU - Kakisaka, Michinori

AU - Hishiki, Takayuki

AU - Kataoka, Michiyo

AU - Takeyama, Haruko

AU - Lim, Chang Kweng

AU - Aida, Yoko

AU - Saijo, Masayuki

PY - 2019/1/22

Y1 - 2019/1/22

N2 - We would like to correct the information on the antibody used in this study. In Fig. 5 of the article, cellular β-actin was detected as an internal control using anti-β-actin antibody (Fujifilm Wako Pure Chemicals, #017-24573). Recently, however, the manufacturer/provider informed us that the antibody reacts with cellular γ1-actin, but do not react with cellular β-actin. Consequently, we detected cellular γ1-actin molecules in the experiment. Fortunately, expression pattern of γ1-actin is similar to that of β-actin in most of cultured cells and, therefore, the alteration of the target molecules does not affect our interpretations and conclusions. The name of the antibody has been corrected in the paper. We apologize for any inconvenience and confusion caused by this error.

AB - We would like to correct the information on the antibody used in this study. In Fig. 5 of the article, cellular β-actin was detected as an internal control using anti-β-actin antibody (Fujifilm Wako Pure Chemicals, #017-24573). Recently, however, the manufacturer/provider informed us that the antibody reacts with cellular γ1-actin, but do not react with cellular β-actin. Consequently, we detected cellular γ1-actin molecules in the experiment. Fortunately, expression pattern of γ1-actin is similar to that of β-actin in most of cultured cells and, therefore, the alteration of the target molecules does not affect our interpretations and conclusions. The name of the antibody has been corrected in the paper. We apologize for any inconvenience and confusion caused by this error.

UR - http://www.scopus.com/inward/record.url?scp=85060529065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060529065&partnerID=8YFLogxK

U2 - 10.1007/s00705-018-4107-0

DO - 10.1007/s00705-018-4107-0

M3 - Comment/debate

C2 - 30474754

AN - SCOPUS:85060529065

SN - 0304-8608

VL - 164

SP - 235

JO - Archives of Virology

JF - Archives of Virology

IS - 1

ER -